Gomisin A induces Ca2+-dependent activation of eNOS in human coronary artery endothelial cells

J Ethnopharmacol. 2009 Sep 7;125(2):291-6. doi: 10.1016/j.jep.2009.06.028. Epub 2009 Jul 3.

Abstract

Aim of the study: Gomisin A (GA) is a small molecular weight lignan contained in Fructus Schisandrae, the dried seed of Schisandra chinensis which is widely used as a tonic in traditional Korean medicine. We previously demonstrated that GA induces endothelium-dependent and -independent relaxation in rat thoracic aorta, however the signaling pathways involved was not clarified. In this study, we examined whether GA could actually induce nitric oxide (NO) production and clarified the mechanism in cultured human coronary artery endothelial cells (HCAEC).

Results: Treatment of HCAEC with GA induced NO production in a time- and concentration-dependent manner in association with an enhanced endothelial NO synthase (eNOS) activity with an increased cytosolic translocation of eNOS. Both GA-induced NO production and eNOS activation were attenuated by pretreatment of the cells with EGTA, an extracellular Ca(2+) chelator, and BAPTA-AM, an intracellular Ca(2+) chelator, but not by LY 294002, a PI3-kinase/Akt inhibitor, suggesting involvement of Ca(2+). Furthermore, GA rapidly increased the intracellular Ca(2+) concentration, which was abolished in Ca(2+) free media.

Conclusion: Taken together, our results suggest that GA induces Ca(2+)-dependent activation and translocation of eNOS in HCAEC, events linked to NO production and thereby endothelial-dependent vasorelaxation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium / blood
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Chromones / pharmacology
  • Coronary Vessels
  • Cyclooctanes / isolation & purification
  • Cyclooctanes / pharmacology*
  • Dioxoles / isolation & purification
  • Dioxoles / pharmacology*
  • Dose-Response Relationship, Drug
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Endothelial Cells / drug effects*
  • Endothelial Cells / enzymology
  • Enzyme Inhibitors / pharmacology
  • Fruit
  • Humans
  • Lignans / isolation & purification
  • Lignans / pharmacology*
  • Morpholines / pharmacology
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide Synthase Type III / blood*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Schisandra / chemistry*
  • Time Factors
  • Vasodilator Agents / isolation & purification
  • Vasodilator Agents / pharmacology*

Substances

  • Chelating Agents
  • Chromones
  • Cyclooctanes
  • Dioxoles
  • Enzyme Inhibitors
  • Lignans
  • Morpholines
  • Plant Extracts
  • Vasodilator Agents
  • 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester
  • Nitric Oxide
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Egtazic Acid
  • schizandrol B
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Calcium